GLOBUS MEDICAL INC (GMED) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-09

GLOBUS MEDICAL INC (GMED) has filed 2 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-09. 2 Form 8-K material event filings were reported by GMED in the last 90 days. 1 Form 144 notices of proposed sale were filed for GMED stock. InsiderAlpha tracks every GMED SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About GLOBUS MEDICAL INC (GMED)

SEC CIK	0001237831

90-Day SEC Filing Activity

Form 4 filings (90d)	2
Form 8-K filings (90d)	2
Form 144 notices (90d)	1
Latest Form 4 filing	2026-06-09

Recent GMED Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-06-05	Davidar David D	Insider	M — Option exercise	25.0K	$26.27	$657K	SEC
2026-06-05	Davidar David D	Insider	S — Open-market sale	25.0K	$80.76	$2.02M	SEC
2026-06-04	RHOADS ANN D	Insider	M — Option exercise	25.0K	$26.27	$657K	SEC
2026-02-25	Huller Kelly	EVP, GC, Corporate Secretary	M — Option exercise [10b5-1]	20.0K	$43.58	$872K	SEC
2026-02-25	Huller Kelly	EVP, GC, Corporate Secretary	S — Open-market sale [10b5-1]	20.0K	$94.50	$1.89M	SEC
2026-02-12	Huller Kelly	EVP, GC, Corporate Secretary	S — Open-market sale [10b5-1]	10.0K	$87.67	$877K	SEC
2026-02-12	Huller Kelly	EVP, GC, Corporate Secretary	M — Option exercise [10b5-1]	10.0K	$45.64	$456K	SEC
2026-01-08	Kline Kyle	Senior Vice President, CFO	M — Option exercise [10b5-1]	3.6K	$51.87	$186K	SEC
2026-01-08	Kline Kyle	Senior Vice President, CFO	S — Open-market sale [10b5-1]	3.6K	$101.10	$363K	SEC
2026-01-08	Norwalk Leslie V	Insider	S — Open-market sale [10b5-1]	2.0K	$101.10	$202K	SEC
2025-12-12	Norwalk Leslie V	Insider	S — Open-market sale [10b5-1]	4.0K	$88.85	$355K	SEC
2025-12-08	Paul David C	Executive Chairman	M — Option exercise	34.4K	$25.52	$877K	SEC
2025-12-01	Kline Kyle	Senior Vice President, CFO	S — Open-market sale [10b5-1]	18.5K	$90.00	$1.67M	SEC
2025-12-01	Kline Kyle	Senior Vice President, CFO	M — Option exercise [10b5-1]	4.9K	$63.68	$312K	SEC
2025-12-01	Kline Kyle	Senior Vice President, CFO	M — Option exercise [10b5-1]	5.0K	$64.44	$322K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for GLOBUS MEDICAL INC (GMED). Updated in real time as new filings are submitted to the SEC.

Most-Active GMED Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Davidar David D	3	$2.68M
RHOADS ANN D	2	$657K

Recent GMED Form 8-K Material Events

2026-06-04 — Item 5.02, 5.07, 9.01 [SEC]
2026-05-07 — Item 2.02, 9.01 [SEC]
2026-03-23 — Item 5.02, 7.01, 9.01 · Leadership · neutral [SEC]
John A. DeFord, Ph.D., a member of Globus Medical's Board of Directors, resigned effective immediately on March 23, 2026. The resignation was not due to any disagreement with the Company.
2026-02-24 — Item 2.02, 9.01 · Earnings · neutral [SEC]
Globus Medical issued a press release on February 24, 2026 reporting its sales and operating results for Q4 2025 and full-year 2025. This is a routine quarterly earnings announcement furnished under Item 2.02 of Form 8-K, with the actual financial data contained in the attached p

Recent GMED Form 144 Notices of Proposed Sale

2026-06-05 — — [SEC]

Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.

Recent Insider Filings

2026-06-09 — Davidar David D (Insider)
2026-06-08 — RHOADS ANN D (Insider)
2026-02-27 — Huller Kelly (EVP, GC, Corporate Secretary)
2026-02-17 — Huller Kelly (EVP, GC, Corporate Secretary)
2026-01-23 — Norwalk Leslie V (Insider)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in GMED insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

GMED Insider Trading — FAQ

What is the latest insider trade for GMED?: GLOBUS MEDICAL INC (GMED) had 2 insider filings in the last 90 days, with the most recent on 2026-06-09. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying GMED stock?: 0 insider purchases of GMED were filed in the last 90 days.
How many insiders are selling GMED stock?: 0 insider sales of GMED were filed in the last 90 days.
Where can I see GMED SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every GMED SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live GMED dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.